| abstract |
A pharmaceutical formulation, comprising: the immune response modifying compound (MRI) 2-methyl-1- (2-methylpropyl) -1H-imidazo [4,5-c] [1,5] naphthyridine-4-amine or one of its pharmaceutically acceptable salts; a fatty acid; an aprotic hydrophobic component miscible with fatty acid and comprising a hydrocarbyl group of 7 or more carbon atoms; and a hydrophilic agent that increases the selected viscosity of cellulose ethers and carbomers. |